Industry News

Caravelle International Group Announces Receipt of Nasdaq Deficiency Notice

SINGAPORE, March 29, 2024 /PRNewswire/ -- Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced that it received a notice from The Nasdaq Stock Market LLC (Nasdaq) indicating that, as a result of not having timely filed its Annual Report on Form 20-F for...

2024-03-29 23:25

EZGO Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

CHANGZHOU, China, March 29, 2024 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we," "our," or the "Company"), a leading short-distance transportation solutions provider inChina, today announced it received a delisting determination notice (the "Delisting Notice") from the Nas...

2024-03-29 23:00

A pressure cooker heats up a heartwarming life on the plateau

BEIJING, March 29, 2024 /PRNewswire/ -- A news report from China.org.cn on people's life in Xizang:   A pressure cooker heats up a heartwarming life on the plateau Songzhuji and her family live in a village in Nyainrong County, Nagqu City, Xizang Autonomous Region. Given the...

2024-03-29 21:42 300

Baird Medical Granted New Class III Certificate by China's NMPA for Ceramic Thyroid Ablation Needle

FRISCO, Texas, March 29, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina and the United States, today announced it has been granted a new Class III certificate by the National ...

2024-03-29 21:37 305

GigaMedia Announces Fourth-Quarter and Full Year 2023 Financial Results

TAIPEI, March 29, 2024 /PRNewswire/ -- GigaMedia Limited (NASDAQ: GIGM) today announced its unaudited financial results for the fourth quarter and full year of 2023. Highlights For 2023, GigaMedia reported revenues of $4.3 million, with a gross profit of $2.4 million, an operating loss of $3.2 ...

2024-03-29 21:00 450

LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC)

* Phase 2 study is underway and LB-P8 is the only live biotherapeutic product currently reported to be in clinical development for the treatment of PSC * FDA's Fast Track designation for LB-P8 underlines the urgent need for treatment options to fulfill the unmet medical needs of people affecte...

2024-03-29 21:00 432

73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis

SAN FRANCISCO, March 29, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their cor...

2024-03-29 20:40 497

Midea RAC Adds New Products to Its CirQHP Family, Offering One-Stop Home Climate Control Solutions for European Households

MILAN, March 29, 2024 /PRNewswire/ -- In a significant move to address the heating and cooling needs of European families, Midea's Residential Air Conditioner Division (Midea RAC) unveiled its new CirQHP Family products at the Mostra Convegno Expocomfort (MCE) 2024. The CirQHP Family is designed ...

2024-03-29 20:13 578

Midea RAC Leads the Way in Sustainable Technology with New Energy-Efficient R290 Products Unveiled at MCE 2024

MILAN, March 29, 2024 /PRNewswire/ -- In a significant stride towards eco-friendly comfort, Midea's Residential Air Conditioner Division (Midea RAC) unveiled its latest energy-saving R290 products at the Mostra Convegno Expocomfort (MCE) 2024 inMilan. Midea RAC also co-hosted a Fireside Chat with...

2024-03-29 20:11 562

Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SHANGHAI, March 29, 2024 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that th...

2024-03-29 20:00 528

JinkoSolar Repurchased 1,753,178 ADSs under Its Share Repurchase Program

SHANGRAO, China, March 29, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that since March 20, 2024, the Company has repurchased 788,178 American deposita...

2024-03-29 18:13 634

IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma

SHANGHAI and NANJING, China and SAN JOSE, Calif., March 29, 2024 /PRNewswire/ -- IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced thatChina National Medical Products Administratio...

2024-03-29 17:20 638

TAL Education Group to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on April 25, 2024

BEIJING , March 29, 2024 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider inChina, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2024 ended February 29, 2024, before the mark...

2024-03-29 17:00 762

U Power Limited Announces 1-for-100 Share Consolidation

SHANGHAI , March 29, 2024 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider inChina, today announced that the Company held an extraordinary general meeting ...

2024-03-29 16:00 765

Timekettle Unlocks Language Barrier-Free Travel This Spring

SHENZHEN, China, March 29, 2024 /PRNewswire/ -- Timekettle, a fast-growing cross-language communication solutions innovator, has successfully wrapped up its #SpringTravelWithTimekettle campaign on Instagram. Running fromMarch 18 to 24, Timekettle encouraged global travelers to share their cherish...

2024-03-29 15:59 620

Techtouch, Inc. ranks 8th in Technology Fast 50 2023 Japan, a ranking of fastest growing technology companies, with a 468.6% revenue growth rate

TOKYO, March 28, 2024 /PRNewswire/ -- Techtouch, Inc. (Headquarter: Tokyo, Japan , President/CEO: Naka Imuta) announced today that it ranked 8th in the 21st Technology Fast 50 Japan, with three-year revenue growth of 468.6%. Technology Fast 50 Japan, held annually by Deloitte Tohmatsu Group, is a ...

2024-03-29 09:15 883

Jacobio Pharma Announces 2023 Annual Results

BEIJING, SHANGHAI and BOSTON, March 28, 2024 Jacobio/PRNewswire/ --  Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue wasRMB63.5 million, the R&D investment wasRMB372 million, the cash and cash equivalent at...

2024-03-29 08:50 1193

Music China Returns in 2024 with Enhanced Quality Boosted by UFI Certification

SHANGHAI, March 29, 2024 /PRNewswire/ -- Music China will come back on October 10th -13th, 2024, at the Shanghai New International Exhibition Centre (SNIEC). Music China is now a UFI (Union of international Fairs) approved international event. This is undoubtedly an international recognition of M...

2024-03-29 08:00 849

Quhuo to Report Unaudited Financial Results for the Second Half and Full Year 2023 on April 3, 2024

BEIJING, March 28, 2024 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on life services inChina, today announced that it will report unaudited financial results for the second half and full year 2023 before the open of t...

2024-03-29 07:00 801

Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade

SEONGNAM, South Korea and ATLANTA, March 28, 2024 /PRNewswire/ --  Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Jessica M...

2024-03-29 06:00 1424
12345 ... 1466